Physicians' Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
This activity has been approved for AMA PRA Category 1 Credit™.
Physicians' Education Resource®, LLC is approved by the California Board of Registered Nursing, Provider #16669.
24th Annual International Congress on Hematologic Malignancies®: Focus on Leukemias, Lymphomas, and Myeloma
Now in its 24th year, the annual International Congress on Hematologic Malignancies®: Focus on Leukemias, Lymphomas, and Myeloma provides practitioners who manage hematologic malignancies with the practical tools to translate emerging data into the best therapy for their patients, to personalize care according to patient and tumor characteristics, and to apply novel treatment strategies to improve patient outcomes.
We are pleased to feature expanded coverage on chimeric antigen receptor (CAR) T cells and immunotherapy in 2020. First, a full afternoon session on Thursday, February 27, 2020, will be dedicated to addressing advances in CAR T-cell therapy for hematologic malignancies, as well as strategies to overcome treatment resistance. Next, sessions on Friday, Saturday, and Sunday will focus on methods to apply state-of-the-art treatment strategies in your clinical practice setting. This engaging and highly interactive meeting will provide ample opportunity for attendees to interact with internationally renowned experts in the management of leukemias, lymphomas, myeloma, myelodysplastic syndrome (MDS), myeloproliferative neoplasms (MPNs), and benign hematologic malignancies. Our faculty will distill practice-changing evidence and recommend how to put this information into clinical context, so that you may apply it to real-world patient-care scenarios. The discussion will also focus on how to proactively mitigate and manage treatment-related toxicities associated with new cellular therapies.
Interspersed throughout the meeting are sessions of Medical Crossfire®, a nationally recognized healthcare communication platform for debate, discussion, and peer exchange. These sessions will provide attendees with the opportunity to explore some of the most challenging clinical situations in the management of hematologic malignancies—treatment scenarios with multiple potential approaches.
This dynamic Congress will inspire participants to reflect on and share the new information they have learned, and to apply these new practices in the clinical setting, with the ultimate goal of improving patient outcomes.
Hot Topics for 2020
- The potential for cell-based therapy to change treatment paradigms in hematologic malignancies
- Best practices for patients with non-Hodgkin and Hodgkin lymphoma
- Recent data on, and approval of, targeted agent-based therapies for patients with chronic lymphocytic leukemia
- State-of-the-art approaches for patients with smoldering and symptomatic multiple myeloma
- Incorporation of novel agents in treatment algorithms for patients with acute leukemias
- Emerging agents for patients with MPNs
- The role of assessment of measurable/minimal residual disease
- How to navigate the value-based landscape of healthcare
Benefits of Attending
- Stay up-to-date with emerging and recently approved agents and approaches for patients with hematologic malignancies
- Learn about molecular profiling and other emerging techniques for risk assessment
- Improve your competence in managing treatment-related adverse events
- Network with your peers and internationally renowned experts in hematology/oncology
This educational activity is directed toward community-based hematologists and medical oncologists, as well as fellows involved in the treatment and management of patients with hematologic malignancies. Nurse practitioners, nurses, physician assistants, pharmacists, researchers, and other healthcare professionals interested in the treatment of hematologic malignancies may also participate.
Chairman and Executive Director
Lymphoma Division Chief, John Theurer Cancer Center
Chief Science Officer, RCCA
Lydia Pfund Chair for Lymphoma Research
Professor of Medicine, Georgetown University
Director, Georgia Cancer Center
Eminent Scholar, Georgia Research Academy
Professor, Emory School of Medicine
Chair, Department of Hematology & Medical Oncology
Chief Medical Officer
Winship Cancer Institute of Emory University
RegistrationRegistration fees include breakfast, breaks, receptions, and e-Syllabus materials.
2 Ways to Register
- Online: Click here.
- Phone: Please call +1-888-949-0045 or +1-609-378-3701 (credit cards only).
Physicians' Education Resource - HEM20
|Nurses, PAs, Other Health Care Professionals||$199||$249|
*FELLOWS registration must be accompanied by a letter from your director/chair stating current fellowship for discount. Cannot be combined with other discounts/coupon codes.
**INDUSTRY is defined by PER® as any person employed by a for-profit organization, including biotech, financial, and pharmaceutical.
For registration assistance, please email email@example.com, or call +1-888-949-0045 or +1-609-378-3701.
A cancellation fee of 25% will be assessed on refunds requested prior to January 9, 2020, and a 50% fee on refunds requested on January 10, 2020, through February 7, 2020. No refunds will be made after February 8, 2020. There is no charge for substitution. Substitutions can only be applied to the same conference and only 2 substitutions will be honored.
In the event of a meeting cancellation, full refunds will be processed within 30 days of the cancellation date.
Physicians' Education Resource®, LLC (PER®) fully complies with the legal requirements of the Americans with Disabilities Act (ADA) and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please notify us in order to receive service: +1-609-378-3701.
Physicians' Education Resource®, LLC, reserves the exclusive rights to all recordings or reproductions of the conference and supporting materials. Unauthorized recording, by any means, is expressly prohibited. This includes, but is not limited to, recording of presentations or reproductions of supporting audio/visual materials, exhibits, and other supporting Continuing Education materials.
By attending a PER® conference, meeting, or related activity ("Events"), all participants, attendees, exhibitors, sponsors, and guests ("you") create an agreement between you and PER® regarding the use and distribution of your image, including but not limited to your name, voice, and likeness ("Image"). By attending the Events, you acknowledge and agree that photographs, video, and/or audio recordings may be taken of you, and you grant permission to PER® (and its agents) to utilize, in perpetuity, your Image in any electronic or print distribution, or by other means hereinafter created, both now and in the future, for any lawful purpose as determined by PER®.
Meeting information is accurate at the time of posting.
PER® complies with the Physician Payments Sunshine Act as a part of the Affordable Care Act (ACA). Accordingly, we may be required to collect information on transfers of value provided to any covered recipient under the ACA.
You must be logged in to PER to register for this meeting
Or Register for PER now